Analysts Set Bath & Body Works, Inc. (NYSE:BBWI) Target Price at $43.13

Shares of Bath & Body Works, Inc. (NYSE:BBWI - Get Free Report) have received an average rating of "Moderate Buy" from the sixteen brokerages that are presently covering the company, MarketBeat reports. Seven research analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $43.13.

A number of analysts have issued reports on BBWI shares. Telsey Advisory Group reaffirmed an "outperform" rating and issued a $42.00 target price on shares of Bath & Body Works in a report on Thursday, September 26th. Wells Fargo & Company dropped their target price on shares of Bath & Body Works from $48.00 to $40.00 and set an "equal weight" rating on the stock in a research report on Wednesday, July 24th. Robert W. Baird reduced their price target on shares of Bath & Body Works from $54.00 to $45.00 and set an "outperform" rating for the company in a report on Thursday, August 29th. JPMorgan Chase & Co. dropped their price objective on shares of Bath & Body Works from $42.00 to $39.00 and set a "neutral" rating on the stock in a report on Thursday, August 29th. Finally, Citigroup reduced their target price on shares of Bath & Body Works from $48.00 to $35.00 and set a "neutral" rating for the company in a research note on Tuesday, August 20th.

Insider Buying and Selling at Bath & Body Works

In other news, CEO Gina Boswell purchased 6,000 shares of the business's stock in a transaction that occurred on Wednesday, October 9th. The stock was purchased at an average cost of $29.64 per share, with a total value of $177,840.00. Following the acquisition, the chief executive officer now directly owns 242,987 shares of the company's stock, valued at approximately $7,202,134.68. This trade represents a 0.00 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Company insiders own 0.27% of the company's stock.

Institutional Investors Weigh In On Bath & Body Works

Hedge funds and other institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. grew its holdings in Bath & Body Works by 4.2% during the 1st quarter. Vanguard Group Inc. now owns 27,398,192 shares of the company's stock worth $1,370,458,000 after acquiring an additional 1,102,124 shares during the last quarter. Lone Pine Capital LLC grew its stake in shares of Bath & Body Works by 15.8% during the second quarter. Lone Pine Capital LLC now owns 11,315,515 shares of the company's stock valued at $441,871,000 after purchasing an additional 1,547,399 shares during the last quarter. Anomaly Capital Management LP acquired a new stake in shares of Bath & Body Works in the second quarter valued at approximately $113,995,000. Sound Shore Management Inc. CT increased its holdings in shares of Bath & Body Works by 10.0% in the second quarter. Sound Shore Management Inc. CT now owns 2,088,703 shares of the company's stock valued at $81,564,000 after purchasing an additional 189,889 shares in the last quarter. Finally, Bessemer Group Inc. raised its position in Bath & Body Works by 5.6% in the 1st quarter. Bessemer Group Inc. now owns 1,448,278 shares of the company's stock worth $72,443,000 after purchasing an additional 76,183 shares during the last quarter. 95.14% of the stock is owned by institutional investors and hedge funds.

Bath & Body Works Stock Performance

Shares of NYSE BBWI traded down $0.01 during mid-day trading on Wednesday, reaching $28.83. 2,910,618 shares of the company traded hands, compared to its average volume of 3,705,043. The company's fifty day moving average is $30.41 and its two-hundred day moving average is $37.59. Bath & Body Works has a fifty-two week low of $26.20 and a fifty-two week high of $52.99. The stock has a market cap of $6.32 billion, a PE ratio of 6.98, a price-to-earnings-growth ratio of 0.95 and a beta of 1.77.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its earnings results on Wednesday, August 28th. The company reported $0.37 EPS for the quarter, topping the consensus estimate of $0.35 by $0.02. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. The firm had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.54 billion. Research analysts forecast that Bath & Body Works will post 3.18 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 6th. Shareholders of record on Friday, August 23rd were paid a dividend of $0.20 per share. The ex-dividend date was Friday, August 23rd. This represents a $0.80 annualized dividend and a yield of 2.77%. Bath & Body Works's dividend payout ratio is currently 19.37%.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.